RYAM Rayonier Advanced Materials Inc.: Price-to-Projected Revenue Ratio

Competition with forestry behemoths and commodity risks are putting pressure on Rayonier Advanced Materials (RYAM), as clearly demonstrated by the shift in forward P/S, where the value remains at 0.30. Demand for biomaterials and debt reduction provide a positive catalyst. Meanwhile, leadership in the specialty cellulose niche and rising contract prices support the stock as biofuel sector projects continue to develop.
Comprehensive metric breakdowns and analytics for rayonieram.com (RYAM)

For the high-purity cellulose market leader Rayonier Advanced Materials (RYAM), whose B2B reputation is critical for the pharmaceutical industry, this indicator serves as a gauge of market confidence in business scaling. An analysis of the forward price-to-sales ratio allows for the determination of the value of each dollar of expected revenue, stripping noise from the trend and capturing the long-term investor consensus regarding the future value of the company's assets.